General Information of Drug (ID: DMFJ2OG)

Drug Name
Collagenase Drug Info
Indication
Disease Entry ICD 11 Status REF
Dermal ulcers 1A36 Approved [1]
Skin burns ME65.0 Approved [1]
Therapeutic Class
Antiulcer Agents
Cross-matching ID
PubChem CID
75007581
TTD Drug ID
DMFJ2OG

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug(s) Targeting Collagen (CO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Vitamin C DMXJ7O8 Adenocarcinoma 2D40 Approved [3]
MRG-201 DM9M5WV Keloid EE60 Phase 2 [4]
Clostridial collagenase DMWTBG8 Discovery agent N.A. Investigative [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Collagen (CO) TTK982E NOUNIPROTAC Breaker [2]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Contact dermatitis with clostridiopeptidase A contained in Noruxol ointment. Contact Dermatitis. 2007 Jun;56(6):361-2.
3 Effects of vitamin C on dark circles of the lower eyelids: quantitative evaluation using image analysis and echogram. Skin Res Technol. 2009 May;15(2):214-7.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am. 2002 Sep;27(5):788-98.